11814389001

Roche

Red Blood Cell Lysis Buffer

Synonym(s):
red blood cells, lysis buffer, RBC Lysis Buffer
Pricing and availability is not currently available.

form

solution

usage

sufficient for 50-500 reactions

packaging

pkg of 100 mL

mfr. no.

Roche

shipped in

wet ice

storage temp.

2-8°C

General description

Used for both DNA and RNA isolation, the buffer is designed for the preferential lysis of red blood cells from human whole blood, yielding intact white blood cells (free of red blood cells) for further applications. This buffer is not intended for use with whole blood from any other species.

Application

Red blood cell lysis buffer has been used in the isolation of PBMCs (peripheral blood mononuclear cells) from HIV infected patients. It has also been used in the isolation of lung cellsm, naive CD8+ T cells and infected cells from the lung.
Used for both DNA and RNA isolation, the buffer is designed for the preferential lysis of red blood cells from human whole blood, yielding intact white blood cells (free of red blood cells) for use in further research applications.
It has been used for the lysis of blood cells in femoral bone marrow, PBMC (peripheral blood mononuclear cells) and human lung adenocarcinoma samples.

Physical form

Ready-to-use solution.

Other Notes

For life science research only. Not for use in diagnostic procedures.

RIDADR

NONH for all modes of transport

WGK Germany

nwg

Flash Point(F)

No data available

Flash Point(C)

No data available

Certificate of Analysis
Certificate of Origin
A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles
Ramirez A, et al.
Vaccine (2018)
Dual Specificity Phosphatase 5 Is Essential for T Cell Survival
Kutty RG, et al.
PLoS ONE, 11(12), 0167246-0167246 (2016)
Quantification of membrane transporter proteins in human lung and immortalized cell lines using targeted quantitative proteomic analysis by isotope dilution nanoLC?MS/MS
Fallon JK, et al.
Journal of Pharmaceutical and Biomedical Analysis, 154, 150-157 (2018)
Anna Guinot et al.
Cancer research, 76(13), 4012-4022 (2016-05-20)
Defining the molecular and cellular roots of lung cancer relapse after initial treatment remains an imperative to improve survival. Here we report that the lung stem cell marker Lgr6 becomes enriched in non-small cell lung cancer (NSCLC) cells during malignant...
Jeroen J A van Kampen et al.
PloS one, 5(7), e11409-e11409 (2010-07-14)
HIV protease inhibitors must penetrate into cells to exert their action. Differences in the intracellular pharmacokinetics of these drugs may explain why some patients fail on therapy or suffer from drug toxicity. Yet, there is no information available on the...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.